Association between Oncologic Drugs Advisory Committee (ODAC) members’ financial conflicts of interest (FCOIs) and recommendations for drug approval by the U.S. Food and Drug Administration (FDA).

Abstract

6582 Background: FDA advisory committees influence decisions relating to the regulatory approval of drugs in the United States. Little is known about whether ODAC members’ FCOIs affect the FDA’s on...